D&O Ongoing Disclosures – Multiple
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
The a2 Milk Company Limited
Date this disclosure made:
16/03/2018
Date of last disclosure:
29/08/2017
Director or senior manager giving disclosure
Full name(s):
Andrew CLARKE
Name of listed issuer:
The a2 Milk Company Limited (Company)
Name of related body corporate (if applicable):
Position held in listed issuer:Chief Scientific Officer
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products: Ordinary Shares
Nature of the affected relevant interest(s):
Legal and beneficial owner
For that relevant interest-
Number held in class before acquisition or disposal:500,000 Ordinary Shares (partly paid)
Number held in class after acquisition or disposal:500,000 Ordinary Shares (fully paid)
Current registered holder(s):
Andrew John Clarke & Susanna Katherine
Sinclair & Matthew Anderson Earles, as
trustees of The Clarke Sinclair Family Trust
Registered holder(s) once transfers are registered:
Andrew John Clarke & Susanna Katherine
Sinclair & Matthew Anderson Earles, as
trustees of The Clarke Sinclair Family Trust
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
Class of underlying financial products:
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying financial
products (if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative(if any):
The price specified in the terms of the derivative (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant
interest in the derivative:
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 1
Details of transactions requiring disclosure-
Date of transaction:
9/03/2018
Nature of transaction:
Payment up of 500,000 partly paid shares in
full
Name of any other party or parties to the transaction (if known):Unknown
The consideration, expressed in New Zealand dollars, paid or recieved for the acquisition
or disposal. If the consideration was not in cash and cannot be readily by converted into a
cash value, describe the consideration:
$272,250 paid up on 500,000 partly paid
ordinary shares
Number of financial products to which the transaction related:
500,000 partly paid ordinary shares were
fully paid up
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were aquired or disposed of during a closed period:
No
Whether prior written clearance was provided to allow the aquisition or disposal to
proceed during the closed period:
N/A
Date of the prior written clearance (if any):
N/A
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
Nature of relevant interest:
For that relevant interest,-
Number held in class:
Current registered holder(s):
For a derivative relevant interest,-
Type of derivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial
products (if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price's specified terms (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative relevant interest,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant
interest in the derivative:
Cerification
I certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all persons
for whom it is made.
Signature of director or officer:
Date of signature:16/03/2018
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorised person:
Notes
Use this form to disclose all the aquisitions and disposals by a director or senior manager
of a listed issuer, or of a related body corporate, or in specified derivatives. The
disclosure must be made within—
(a) 20 working days after the first aquisition or disposal disclosed in this notice
if the aquisitions or disposals are of a kind referred to in section 297(2)(a) of the Financial
Markets Conduct Act 2013; or
(b) in any other case, 5 trading days after the first aquisition or disposal
disclosed in this notice.
---
Appendix 3Y
Change of Director’s Interest Notice
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
(Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity The a2 Milk Company Limited
ABN 97 769 415 292
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for
the director for the purposes of section 205G of the Corporations Act.
Name of Director
Geoffrey Babidge
Date of last notice
1 March 2018
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should
be disclosed in this part.
Direct or indirect interest
Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the
relevant interest.
Geoffrey Babidge’s relevant interest is held on
trust by GCAA Investments Pty Ltd.
Date of change
9 March 2018
No. of securities held prior to change
2,000,000 partly paid ordinary shares.
500,000 fully paid ordinary shares.
Class
Fully paid ordinary shares and partly paid
ordinary shares.
Number acquired
2,000,000 fully paid ordinary shares.
Number disposed
2,000,000 partly paid ordinary shares (as a
result of the payment-up of those shares in
full).
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
NZ$ 1,267,200 paid up on the partly paid
ordinary shares.
No. of securities held after change
2,500,000 fully paid ordinary shares.
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue
of securities under dividend reinvestment plan, participation in buy-back
Full payment of 2,000,000 partly paid
ordinary shares.
Appendix 3Y
Change of Director’s Interest Notice
+ See chapter 19 for defined terms.
Appendix 3Y Page 2 01/01/2011
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should
be disclosed in this part.
Detail of contract
n/a
Nature of interest
n/a
Name of registered holder
(if issued securities)
n/a
Date of change
n/a
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
n/a
Interest acquired
n/a
Interest disposed
n/a
Value/Consideration
Note: If consideration is non-cash, provide details
and an estimated valuation
n/a
Interest after change
n/a
Part 3 –
+
Closed period
Were the interests in the securities or contracts detailed
above traded during a
+
closed period where prior written
clearance was required?
No
If so, was prior written clearance provided to allow the trade
to proceed during this period?
n/a
If prior written clearance was provided, on what date was
this provided?
n/a
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- NZX — NZX Limited: D&O Ongoing Disclosure – Jon Macdonald2017-12-21
“Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: NZX Limited Date this disclosure made: 22-Dec-17 Date of last disclosure: 4-Sep-1…”
- NZX — NZX Limited: D&O Ongoing Disclosures – Multiple2018-06-14
“Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: NZX Limited Date this disclosure made: 15-Jun-18 Date of last disclosure: 3-May-1…”
- OCA — Oceania Healthcare Limited: D&O Ongoing Disclosures – Multiple2018-01-25
“Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and ASX Name of listed issuer: Oceania Healthcare Limited Date this disclosure made: 26-Jan-18 Date of last di…”